Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life
Authors:
Open Access
- 9 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1041505
Abstract
Aim: This study aimed to determine the factors affecting the quality of life of patients with inflammatory bowel disease (IBD) and to construct a disease recurrence prediction model based on these influencing factors.Methods: A prospective, single-center study in China was conducted between October 2020 and March 2021. The quality of life of patients was assessed using the Inflammatory Bowel Disease Questionnaire (IBDQ). Multiple stepwise regression analysis was used to analyze the factors influencing the quality of life of patients with IBD. The chi-square test and the point-biserial correlation analysis were performed to identify factors associated with clinical recurrence. A binary logistic regression model was constructed to predict the recurrence. The receiver operating characteristic curve was used to evaluate the prediction model. Patients with IBD from April 2021 to June 2021 were randomly included for model verification to evaluate the disease recurrence prediction model.Results: The average IBDQ score of patients with IBD was 172.2 ± 35.0 (decreased by 23.2%). The scores of all dimensions of the IBDQ were decreased, especially emotional function and systemic symptoms. Disease activity, age, extraintestinal manifestations (EIMs), and annual household income were important factors influencing the IBDQ scores of patients with ulcerative colitis, and these accounted for ~57.0% of the factors affecting the quality of life. Disease activity, EIMs, and occupational stress were important factors influencing the IBDQ scores of patients with Crohn's disease, and they accounted for approximately 75.1% of the factors affecting the quality of life. Annual household income, occupational stress, and IBDQ scores were independent risk factors for recurrence. The area under the curve of the recurrence prediction model was 81.1%. The sensitivity and specificity were 81.7 and 71.7%, respectively. The Youden index of the model was 0.534. The established recurrence prediction model has good discriminant validity in the validation cohort.Conclusion: The quality of life of patients with IBD was generally poor. The use of factors affecting the quality of life to predict disease recurrence has high predictive value and can support the management of IBD by selecting patients at a higher risk for relapse.Keywords
Funding Information
- National Natural Science Foundation of China (81960108, 82160107, 82170550, U1802282)
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
This publication has 62 references indexed in Scilit:
- Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance TherapyInflammatory Bowel Diseases, 2013
- Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12Inflammatory Bowel Diseases, 2013
- Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ databaseBMC Gastroenterology, 2013
- Labor Participation Among Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisBMC Gastroenterology, 2012
- Validation of the Italian translation of the Inflammatory Bowel Disease QuestionnaireDigestive and Liver Disease, 2011
- Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activityJournal of Psychosomatic Research, 2008
- A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative ColitisGastroenterology, 2007
- Health Psychology: Psychological Adjustment to Chronic DiseaseAnnual Review of Psychology, 2007
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006